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Critical aortic stenosis in the neonate 
A comparison of balloon valvuloplasty and transventricular dilation 
The optimal treatment of critical aortic stenosis in the neonate and infant remains controversial. We 
compared transventricular dilation using normothermic cardiopulmonary bypass and percutaneous 
balloon aortic valvuloplasty with respect to early and late survival, relief of aortic stenosis, degree of 
aortic insufficiency, left ventricular function, and freedom from reintervention. Between July 1987 
and July 1993, 30 neonates and infants underwent transventricular dilation or balloon aortic 
valvuloplasty for critical aortic stenosis. The patients in the transventricular dilation group (n = 21) 
ranged in age from 1 to 59 days (mean age 18.0 days -+ 19.1 days) and the balloon aortic 
valvuloplasty group (n = 9) from 1 to 31 days (mean age 10.0 days - 9.0 days). There were no 
significant differences in weight, body surface area, or aortic anulus diameter between the two groups 
(p = 1.0). Associated cardiovascular nomalies were more common in the transventricular dilation 
group (48%) than in the balloon aortic valvuloplasty group (11%). After intervention, the degree of 
residual aortic stenosis and insufficiency was equivalent in the two groups as assessed by 
postprocedural Doppler echocardiography. Ejection fraction improved within both groups (trans- 
ventricular dilation 39% - 20.2% versus 47% - 22.0%; balloon aortic valvuloplasty 51% -+ 16.1% 
versus 62% -+ 8.4%), and there was no significant difference between groups. The left ventricular 
mass/volume ratio increased within both groups (p < 0.05) but with no significant difference between 
groups (transventricular dilation 1.4 - 0.5 gm/ml versus 1.8 - 0.6 gm/ml; balloon aortic 
valvuloplasty 1.1 -+ 0.6 gm/ml versus 1.7 -+ 0.4 gm/ml). Early mortality in the transventricular 
dilation group was 9.5% and in the balloon aortic valvuloplasty group, 11.1%. There was one late 
death in the transventricular dilation group. Four patients from the transventricular dilation group 
(19%) and two patients from the balloon aortic valvuloplasty group (22%) required reintervention 
for further relief of aortic stenosis. We conclude that both transventricular dilation and balloon 
aortic valvuloplasty provide adequate and equivalent relief of critical aortic stenosis. The treatment 
strategy adopted should depend on ther factors, including associated cardiovascular nomalies, 
vascular access, preoperative condition, and the technical expertise available at ach institution. (J 
THORAC CARDIOVASC SURG 1995;109:147-54) 
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The treatment Of critical aortic stenosis in the 
neonate continues to carry a high mortality. With a 
few exceptions, 1 the reported hospital mortality has 
ranged from 22% to 58%. 2-12 The morphologic 
substrate in neonates with symptomatic aortic ste- 
nosis represents a wide spectrum of abnormalities 
and often includes patients with aortic annular 
hypoplasia, valvular dyplasia, hypoplasia of the left 
ventricle, mitral valve anomalies, and endocardial 
fibroelastosis. Treatment protocols and outcome 
analysis are, therefore, difficult to standardize and 
compare. A number of surgical techniques have 
been developed in an attempt to treat patients 
with congenital aortic stenosis. Direct exposure of 
the aortic valve has been the established treat- 
ment in the past. However, this procedure in the 
neonate is frequently unrewarding because the com- 
missures are poorly defined and the anulus is small. 
Percutaneous balloon aortic valvuloplasty (BAV) is 
well established in older children and effectively 
reduces the severity of valvular stenosis 13qs with 
acceptable short-term and intermediate-term re- 
suits.19, 20 
At the C. S. Mott Children's Hospital of the 
University of Michigan Medical Center, we 21-24 have 
taken an active role in applying transcatheter ther- 
apy for a number of congenital heart defects. How- 
ever, the frequently unstable clinical condition of 
many of these neonates with critical aortic stenosis, 
as well as the problems encountered with femoral 
arterial access in small infants requiring relatively 
large angioplasty catheters, led us to adopt the opera- 
tive approach of transventricular dilation (TVD) using 
cardiopulmonary b pass. This technique allows rapid 
stabilization of a hemodynamically compromised pa- 
tient with circulatory support while avoiding the myo- 
cardial ischemia required to expose the aortic valve for 
open valvotomy. The development of smaller angio- 
plasty catheters z5 and the introduction of the now 
preferred transumbilical rtery approach ave led us 
once again to examine the relative merits of both BAV 
and TVD. We therefore reviewed our recent experi- 
ence with both procedures with respect o early and 
late survival, relief of aortic stenosis, degree of aortic 
insufficiency, left ventricular function, and freedom 
from reintervention. 
Methods 
Patient data. Between July 1987 and July 1993, 30 
neonates and infants underwent TVD (n = 21) or BAV 
(n = 9) for critical aortic stenosis at C. S. Mott Children's 
Hospital, the University of Michigan Medical Center. All 
patients with biventricular hearts, as well as atrioventric- 
Table I. Preoperative hemodynamics 
TVD BA V* 
Anulus (mm) 6.9 '-+ 1.8 7.5 -4- 0.8 
Gradient (mean) 33.8 -+ 15.9 42.0 _+ 15.7 
LVEF (%) 39.0 -+ 20.2 51.1 _+ 16.1 
LVEDV (ml/m 2) 82.1 -+ 50.0 54.8 + 24.3 
Mass/volume (gm/ml) 1.4 _+ 0.5 1.1 + 0.2 
TVD, Transventricular dilation; BAV, balloon aortic valvuloplasty; LVEF, 
left ventricular ejection fraction; LVEDV, left ventricular end-diastolic 
volume; mass~volume, leftventricular mass/volume. 
*p = not significant compared with TVD. 
Table II. Associated anomalies 
No. of patients 
awo (n = 21) 
Mitral stenosis 2 
Ventricular septal defect 2 
Patent ductus arteriosus 10 
Coarctation ofthe aorta 5 
Tetralogy of Fallot 1 
BAV (n = 9) 
Patent ductus arteriosus 6 
ular and ventriculoarterial concordance, were included for 
review. Patients with hypoplastic left heart syndrome, 
univentricular atrioventricular connection, common 
atrioventricular valve orifice, or truncus arteriosus were 
excluded from the study. The decision to perform TVD or 
BAV was predicated on the suitability of the umbilical 
arteries and often the preference of the referring physi- 
cian. All measurements were made with Doppler echo- 
cardiography and reported as the mean value +- the 
standard eviation. 
TVD. TVD was performed on 21 patients whose ages 
ranged from 1 to 59 days (mean 18.0 + 19.1 days). Their 
weights ranged from 1.5 to 5.6 kg (mean 3.1 + 1.0 kg). All 
patients were in moderate to severe congestive heart 
failure, 10 were receiving an infusion of prostaglandin E1 
to maintain patency of the ductus arteriosus, and 7 were in 
hemodynamically unstable condition. Patients were con- 
sidered to be in unstable condition if they were persis- 
tently hypotensive or acidotic despite maximal support. 
Only eight of the patients underwent preoperative cathe- 
terization. Preoperative aortic anulus diameters ranged 
from 5.0 to 12.5 mm (mean 6.9 -+ 1.8 mm). Peak instan- 
taneous aortic valve gradients ranged from 16 to 98 mm 
Hg (mean 59.8 -2-_ 25.2 mm Hg) and mean gradients varied 
from 12 to 53 mm Hg (meah 33.8 -+ 15.9 mm Hg). Left 
ventricular ejection fraction ranged from 14% to 71% 
(mean 39.0% + 20.2%), left ventricular end-diastolic 
volume from 14 to 192 ml/m 2 (mean 82.1 -+ 50.0 ml/m2), 
and the mean left ventricular mass/volume ratio was 1.4 + 
0.3 gm/ml (Table I). Associated efects consisted of mitral 
stenosis in two patients, restrictive ventrieular septal de- 
fect in two, patent ductus arteriosus in ten, coarctation i
five, and tetralogy of Fallot in one patient (Table II). 
In those patients without major associated anomalies 
requiring repair, TVD was performed with normothermic 
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Table I I I .  Mortality 
Early La~ 
No. % No % 
TVD (n = 21) 2 9.5 1 5.3 
BAV* (n = 9) 1 11.0 0 
*p = Not significant. 
cardiopulmonary b pass. In one patient, TVD was per- 
formed without bypass through a left thoracotomy during 
simultaneous coarctation repair. Cardiopulmonary b pass 
time ranged from 11 to 22 minutes with a mean of 14 
minutes. No period of myocardial ischemia was necessary 
because the valve was not visualized. The heart was 
elevated and a pursestring suture placed in the left 
ventricular apex. Gradual dilation achieved with progres- 
sively larger dilators was then performed by passing the 
dilators through the left ventricular apex along the ven- 
tricular septum and across the aortic valve until they were 
palpated in the ascending aorta (Fig. 1). The optimal 
maximal dilator size was 1 mm larger than the preopera- 
tive echocardiographic measurement of the aortic anulus 
and ranged from 6 to 10 mm. 
BAV. Nine patients underwent BAV. Their ages ranged 
from 1 to 31 days (mean 10.0 -+ 9.0 days) and weights 
from 2.2 to 4.8 kg (mean 3.7 --+ 0.7 kg). All of the pa- 
tients were in congestive heart failure, although none 
were in hemodynamically unstable condition. Six of the 
patients were receiving prostaglandin E1 to maintain 
ductal patency. One patient had undergone a previ- 
ous open aortic valvotomy and had significant residual 
aortic stenosis. The aortic anulus diameters ranged from 
6.5 to 7.9 mm (mean 7.5 -+ 0.8 ram). Peak instantaneous 
aortic valve gradients ranged from 33 to 100 mm Hg 
(mean 68 _+ 25.9 mm Hg) and the mean gradients ranged 
from 20 to 61 mm Hg (mean 42 _+ 15.9 mm Hg). The left 
ventricular ejection fraction ranged from 36% to 81% 
(mean 51.1% _+ 16.1%), and the left ventricular end- 
diastolic volume varied from 31.1 to 104 ml/m 2 (mean 54.8 
_+ 24.3 ml/m2). The mean left ventricular mass/volume 
ratio measured 1.1 _+ 0.2 gm/ml (see Table I). Associ- 
ated cardiovascular lesions included a patent ductus ar- 
teriosus in six patients and a variant of hypoplastic left 
heart syndrome, determined after treatment in one (see 
Table II). 
The technique for BAV has been previously described 
in detail. 25 We prefer the transumbilical pproach, when 
possible, using an arterial catheter in each umbilical ar- 
tery and a venous catheter positioned across the foramen 
ovale into the left ventricle. This allows for simultaneous 
measurement of left ventricular and aortic pressures 
throughout the procedure. The balloon size is chosen to 
approximately equal the valve anulus diameter as esti- 
mated by echocardiography. After dilation, an aortogram 
is performed to evaluate the degree of aortic valve 
insufficiency. 
Statistical evaluation. All data are reported as mean -
standard eviation. The two treatment groups were com- 
pared by the Student's t test for continuous data and the 
Fisher exact est for categorical data. Ap value < 0.05 was 
required to indicate a significant result. 
Fig. 1. Operative technique demonstrating antegrade TVD 
using blunt dilators through an apical pursestring suture. 
Results 
TVD group. There were two hospital deaths in 
the TVD group (9.5%, 70% confidence interval 
[CI]: 4.7% to 18.3%) (Table III). Both deaths 
resulted from low cardiac output. One patient was in 
extremely poor condition before the operation and 
the second was a patient with borderline left ven- 
tricular hypoplasia (volume about 25 ml/m 2) whose 
ventricular function continued to deteriorate in the 
postoperative period. The one late death involved a 
child with multiple associated cardiovascular nom- 
alies, including multiple ventricular septal defects, 
aortic coarctation, and pulmonary vein stenosis, who 
had undergone intraoperative pulmonary vein stent- 
ing. She died awaiting transplantation. The overall 
survival in the TVD group was 86%. 
Among the remaining 19 patients, follow-up 
ranges from 6 to 94 months, with a mean follow-up 
of 56.5 _ 24.9 months. The residual peak instanta- 
neous pressure gradient across the aortic valve 
ranged from 0 to 73 mm Hg (mean 29.1 _ 19.2 mm 
Hg). The residual mean pressure gradient varied 
from 3 to 43 mm Hg (mean 18.9 _+ 10.9 mm Hg). 
The left ventricular end-diastolic volume ranged 
from 20 to 135 ml/m 2 (mean 73.6 ___ 51.5 ml/mZ). The 
left ventricular ejection fraction ranged from 12% to 
77% (mean 47.7% _ 22.0%), as seen in Table IV. 
Five patients had no echocardiographic evidence of 
aortic insufficiency, ten patients had mild insuffi- 
ciency, three had moderate insufficiency, and one 
patient had moderate to severe insufficiency that has 
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Table IV. Hemodynamic results 
TVD* BAV*? 
(n=19) (n =8) 
Gradient (mean) 18.9 -+ 10.9 28.7 _+ 10.9 
LVEF (%) 47.7 -+ 22.0 62.0 _+ 8.4 
Mass/volume (gm/ml) 1.8 +- 0.6 1.7 -+ 0.4 
Gradient and left ventricular ejection fraction were measured at hospital 
discharge. Left ventricular mass/volume ratio was measured at latest 
follow-up echocardiogram. 
*p < 0.05 compared with preoperative value. 
"~p = not significant compared with TVD. 
progressed over the course of 4 years (Table V). The 
left ventricular mass/volume ratio increased from 
1.37 _+ 0.34 gm/ml to 1.85 +_ 0.19 gm/ml. 
One patient, who underwent TVD followed by 
BAV, subsequently underwent a Norwood proce- 
dure because of poor left ventricular function. This
was followed by staging to a successful Fontan 
procedure. Two patients from the initial TVD group 
required a subsequent BAV. The first underwent 
aortic valve replacement with a pulmonary autograft 
6 years later for progressive aortic stenosis and 
insufficiency. The other patient had a residual co- 
arctation that was successfully dilated concomitantly 
with the BAV. One additional patient required open 
valvotomy and resection for progressive subvalvular 
and valvular aortic stenosis 4 years after the initial 
procedure. The remaining 14 patients have required 
no additional procedures (Fig. 2). 
BAV group. The BAV group consisted of nine 
patients. Ten procedures were performed in these 
patients. Seven of the dilations were done via a trans- 
umbilical approach. The remaining three procedures 
were accomplished via the femoral artery. One patient 
required a second valvuloplasty for persistent symp- 
toms and a residual aortic valve pressure gradient of 95 
mm Hg at 3 months of age (see Fig. 2). The one early 
death was due to low cardiac output and there have 
been no late deaths, for a mortality rate of 11.1% 
(70% CI 4.2% to 26.3%). The external iliac artery was 
injured uring one of the transfemoral procedures, but 
without significant vascular compromise to the in- 
volved extremity. 
Survivors have been observed for 12 to 56 months 
(mean 37.2 _+ 15.2). The residual peak instanta- 
neous pressure gradient across the aortic valve 
ranged from 25 to 60 mm Hg (mean 43.5 + 15.6 mm 
Hg) and the residual mean pressure gradient varied 
from 17 to 45 mm Hg (mean 28.7 _+ 10.9 mm Hg). 
Aortic insufficiency was absent in three patients, 
mild in three patients, moderate in one patient, and 
moderate to severe in one patient. Left ventricular 
Table V. Postprocedural aortic insuficiency 
Grade 
0 1+ 2+ 3+ 4+ 
TVD (n = 19) 5 10 3 1 0 
BAV (n = 8) 3 3 1 1 0 
Results appear similar; however, because of the mall numbers of patients 
in each group, no statement can be made concerning statistical ignifi- 
cance. 
ejection fraction increased from a mean of 51.1% _+ 
16.1% to 62.0% +__ 8.4% and the left ventricular 
end-diastolic volume fell to 47.6 + 21.2 ml/m 2. The 
left ventricular mass/volume ratio increased from 
1.12 + 0.2 to 1.74 +_ 0.2 gm/ml at he most recent 
echocardiogram. 
The two techniques studied had similar mortality 
rates (TVD 9.5% and BAV 11.1%). Both TVD and 
BAV were successful in relieving the anatomic left 
ventricular outflow tract obstruction as evidenced by 
the decline in the mean transvalvular gradients: 
TVD (mean 33.8 + 15.9 mm Hg to 18.9 + 10.9 mm 
Hg) and BAV (mean 42 _+ 15.9 mm Hg to 28.7 _+ 
10.9 mm Hg). This represents a significant differ- 
ence within each group but there is no significant 
difference between the treatment groups. This re- 
duction in the mean gradient is especially encour- 
aging when viewed in light of the improvement in
left ventricular function. The left ventricular ejec- 
tion fraction in the TVD group rose from a mean of 
39% + 20.2% to 47% +_ 22.0%, and in the BAV 
group it increased from a mean of 51% +_ 16.1% to 
62% _+ 8.4%. Because of the small number of 
patients in each group, the degree of aortic insuffi- 
ciency could not be statistically evaluated but does 
appear to be similar in both treatment groups. Last, 
the need for reintervention is higher in the surgical 
group (TVD 22.2%) than in the catheterization 
group (BAV 12.5%); however, the follow-up in the 
surgical group is longer as well (TVD 56.5 +_ 24.9 
months, BAV 37.2 + 15.2 months). 
Discussion 
Surgical therapy for critical aortic stenosis in 
neonates carries a significant perioperative mortal- 
ity. A variety of different approaches have been 
proposed for the treatment ofcritical aortic stenosis 
in the neonate. These methods include open valvot- 
omy with inflow occlusion or cardiopulmonary b - 
pass,6-8, 26 TVD with or without cardiopulmonary 
bypass,4,11, 27-29 intraoperative BAV via the left ven- 
tricular apex, 3°' 3J and percutaneous BAV. 2°' 32, 33 Ne- 
onates with critical aortic stenosis present aformidable 
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Fig. 2. Reintervention after TVD and BAV. Valvotomy, open valvotomy; Ross procedure, pulmonary 
autograft; BAV/Coarc, simultaneous BAV and dilation of recurrent aortic coarctation; Norwood, first-stage 
palliation of hypoplastic left heart syndrome, AS, aortic stenosis. 
challenge because of the frequently associated unsta- 
ble hemodynamic status, hypertrophied and irritable 
myocardium prone to ventricular arrhythmias, limited 
myocardial reserve, and the frequency of additional 
cardiac lesions such as left ventricular fibroelastosis, 
mitral stenosis, and left ventricular hypoplasia. 
Although a few studies have reported good results 
with open aortic valvotomy, 1' 34 in most series the 
mortality has remained high. 3-12 This may be be- 
cause, in part, congenital aortic stenosis is a heter- 
ogeneous and complex disorder in which the aortic 
valvular and annular substrate may not be conducive 
to direct operative intervention. Aggressive at- 
tempts at valvotomy may lead to a high incidence of 
postoperative aortic insufficiency and further left 
ventricular failure. In addition, the need to subject 
the heart to an additional ischemic period during 
the procedure may result in a further deterioration 
of left ventricular function. Trinkle and associates ~1
first described TVD as a simple and effective tech- 
nique of closed aortic valvotomy in infants. All four 
patients urvived the perioperative period with sig- 
nificant reduction in transvalvular gradients and 
minimal aortic insufficiency. Trinkle, Grover, and 
Arom 28 later reported continued benefit in the same 
group of patients at a follow-up period of 3 to 6 
years. TVD using cardiopulmonary b pass provides 
reliable circulatory support, avoids myocardial isch- 
emia, and allows for a conservative yet effective 
valvotomy with minimal aortic regurgitation. We 
believe that the antegrade technique tends to seek 
the "true" orifice, making cusp perforation unlikely. 
The gradual dilation also promotes opening along 
naturally fused commissures. These mechanisms 
reduce the likelihood of significant aortic insuffi- 
ciency. This approach optimizes prompt relief of the 
severe left ventricular pressure overload while min- 
imizing left ventricular volume overload from valve 
regurgitation and myocardial injury from surgical 
ischemia. Similar to Trinkle's group, we have seen 
dramatic lasting improvement with the majority of 
patients being free from reintervention at a mean 
follow-up period of 53 months. As with all surgical 
procedures, this must be balanced against he infre- 
quent yet possible complications of the procedure 
itself and the increased technical difficulty of subse- 
quent operations hould they be necessary. 
On the other hand, transcatheter therapy avoids 
the need for general anesthesia, sternotomy, cardio- 
pulmonary bypass, and an incision in the left ven- 
tricular apex. In the infant, BAV produces a decline 
in the transvalvular gradient by two possible mech- 
anisms: stretching of valve tissue and rupture of 
commissural fusion. These are not unlike the mech- 
anisms involved with closed TVD; however, the 
valvuloplasty is approached in retrograde fashion 
against he flow of blood and around the bend of the 
ascending aorta. This geometry may tend to direct 
the guidewire rightward into the noncoronary cusp. 
If cusp perforation occurs and is unrecognized, 
subsequent balloon dilation will create severe aortic 
insufficiency. 33 BAV in neonates with critical aortic 
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stenosis has been reported previously by a few 
centers with effective gradient reduction and accept- 
able degrees of aortic regurgitation. 2° The risks of 
BAV continue to include inadvertent unrecognized 
cusp perforation with resultant severe aortic insuf- 
ficiency and femoral arterial injury. However, as 
previously reported by our group, the availability of 
smaller catheters has made the umbilical artery 
approach the procedure of choice in the neonate, 
preserving the femoral arteries for future catheter- 
ization should that become necessary. 25
Zeevi and associates 6 compared BAV and open 
aortic valvotomy in an unselected group of 32 
consecutive neonates with critical aortic stenosis. 
They found that the efficacy and mortality of surgi- 
cal valvuloplasty and BAV were similar, but with a 
higher reoperation rate and mortality rate than we 
experienced using TVD. It is also clear from their 
work and that of multiple other groups that left 
ventricular size has a highly significant correlation 
with outcome in neonates with critical aortic steno- 
sis, regardless of the procedure selected. 35-37 Al- 
though the delineation of hypoplastic left heart 
syndrome from critical aortic stenosis can be diffi- 
cult, we use certain criteria to select hose patients 
best suited for single-ventricle type repairs. A mitral 
valve anulus of less than 8.0 mm, a left ventricular 
end-diastolic volume of less than 20 ml/m 2, an aortic 
valve anulus of less than 5.0 ram, a non-apex- 
forming left ventricle, and the presence of severe 
subaortic stenosis are all variables we believe place 
the patient into the hypoplastic left heart syndrome 
category. Patients with significant left ventricular 
hypoplasia re best treated with staged reconstruc- 
tion leading to an eventual Fontan repair. 
As can be inferred from the large range and 
standard deviation in the measurements of left 
ventricular end-diastolic volume and mass, as well as 
left ventricular ejection fraction, we are dealing with 
two different subsets of patients. One group of 
patients demonstrated relatively well-preserved ven- 
tricular function, small chamber sizes, and greatly 
hypertrophied left ventricles. The second group of 
patients was characterized by dilated left ventricular 
chambers and declining ventricular function. Be- 
cause of the small numbers of patients in each 
category, we were unable to comment on any defi- 
nite difference in outcome; however, these patients 
appear to represent a continuum progressing from 
left ventricular hypertrophy to chamber dilatation. 
This may be a result of continued left ventricular 
pressure overload and relative myocardial ischemia. 
Also, it is encouraging to see the normalization of 
the mass/volume ratio in these infants after dilation. 
We surmise that relief of the left ventricular outflow 
obstruction without superimposing significant aortic 
insufficiency allows the left vcntricular mass and/or 
volume to regress, improves the myocardial oxygen 
supply, and results in a more efficiently functioning 
left ventricle. 
A limitation of this study is the potential for 
selection bias. The greater prevalence of associated 
anomalies and greater degree of hemodynamic n- 
stability in the TVD group indicate a population at 
greater isk. This may tend to obscure a potential 
benefit of TVD when compared with BAV. 
Optimal treatment of critical neonatal aortic ste- 
nosis depends on prompt and accurate anatomic 
diagnosis and medical stabilization before interven- 
tion. Ventilation, inotropic support, and the treat- 
ment of acidosis before intervention are often 
beneficial. In particular, the administration of a 
prostaglandin fusion is extremely helpful in treat- 
ing low cardiac output by allowing the right ventricle 
to perfuse the systemic circulation through the 
ductus arteriosus. Given the similar results of the 
two procedures as demonstrated in this report, 
the decision on the optimal procedure should rest 
on a variety of other factors, including vascular 
access, associated lesions necessitating surgical in- 
tervention, and institutional expertise. Currently, in 
stable neonates with patent umbilical arteries and 
no associated anomalies requiring repair, we prefer 
BAV. When umbilical artery access is not possible, 
we prefer to use TVD to preserve the femoral artery 
access for future percutaneous intervention. Alter- 
natively, balloon dilation through the carotid artery 
has been used in some patients. 3s In the presence of 
coexisting cardiovascular conditions uch as coarc- 
tation of the aorta, we prefer an operative approach 
to include TVD and concomitant repair of the 
associated lesion. 
The debate over the optimal treatment of critical 
aortic stenosis in the neonate continues. We believe 
that TVD and BAV provide the best short-term and 
intermediate-term results to a problem that will 
likely require multiple interventions over the pa- 
tient's lifetime. 
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Discussion 
Dr. Michel N. Ilbawi (Oak Lawn, Ill.). We differ in our 
approach to critical aortic stenosis. We invariably treat 
these patients with open extended valvuloplasty, which 
has a risk factor of less than 5% and good long-term 
outcome. 
How do you explain, in your hands, the superiority of 
dilation over open valvotomy? How can a blind procedure 
better define the commissure than an open one? 
Dr. Giovanni Stellin (Padova, Italy). It seems that the 
"nonpatency" of the umbilical artery is a limiting factor 
for you to perform aortic balloon dilation in neonates. In 
your institution, critical aortic stenosis in neonates has 
been managed, in the last 3 years, by balloon dilation 
utilizing the right carotid artery as arterial access, with no 
complications. I wonder if you have any experience with 
this approach, which seems to be very good, according to 
our cardiologists. 
Obviously the carotid artery is not ligated at the end of 
the procedure. The patency of the artery is checked by 
two-dimensional echocardiography and Doppler studies 
before discharge. So far, we have not seen any occlusion 
or stenosis. 
Dr. Ralph D. Siewers (Pittsburgh, Pa.). I would like to 
add to the comments of Dr. Stellin regarding the carotid 
artery approach to balloon dilation in critical aortic ste- 
nosis. Our cardiologists are happy with this approach and 
have had no trouble passing the balloon catheter so long 
as we extend the head, which tends to straighten the angle 
of the innominate artery. It gives them a very direct 
approach. We have been able to repair the carotid artery 
in each case with no complications. Our experience now 
numbers approximately 14 of these patients at the Chil- 
dren's Hospital of Pittsburgh. We agree that this does not 
give us the advantage of cardiopulmonary b pass resusci- 
tation, but we have not needed mechanical support for
resuscitation i these neonates. 
Dr. Gerhard Ziemer (Hannover, Germany). This discus- 
s ion shows that you are allowed to do anything to the 
stenotic aortic valve so long as you can come up with a 
mortality of no more than 10% accompanied by a low 
reoperation rate. We know that this is possible with each 
of the procedures mentioned. In Hannover we use several 
of these procedures and make a somewhat individual 
decision about what to do with a certain patient. For 
example, when we have a very sick baby at the Children's 
Hospital where no cardiopulmonary bypass option is 
given, we do not transport he patient to our unit, but 
rather do an open valvotomy with inflow occlusion. Other 
patients are operated on with extracorporeal circulation. 
Older infants may undergo balloon-valve rupture per- 
formed by pediatric ardiologists. 
Dr. John J. Lamberti (San Diego, Calif.). I cannot sit 
here and listen to this discussion without commenting on 
your remarks. You are espousing the standard teachings 
regarding aortic stenosis in infancy. I was also taught that 
the aortic valve cannot be approached irectly in the 
infant. I now know that if you take the time to put the 
patient on bypass, use cardioplegia, nd decrease pump 
flow for a few minutes, you can get a really good look at 
the valve. In 1988, at the meeting of this Association in 
Boston, Massachusetts, Dr. Messmer from Aachen, Ger- 
many, discussed a similar paper on neonatal aortic steno- 
sis. Dr. Messmer pointed out that aortic valvotomy under 
direct vision in the neonate permits precise opening of the 
commissures, as well as trimming of obstructive lumps 
(excrescences) on the leaflets ( J THORAC CARDIOVASC 
SURe 1990;99:683). Since that time we have used the 
technique in four patients with excellent early results. 
I think your paper is an excellent report, but I am 
surprised that your group, which advocates early primary 
repair of tetralogy of Fallot, would put a patient on bypass 
and then not actually look at the valve. It is my belief that 
open techniques are appropriate for congenital aortic 
stenosis in the infant. One technical point: Although the 
aorta may be small, it takes only a few extra moments to 
place a patch of pericardium at the site of the aortotomy. 
I also recognize that we do not often have a chance to 
operate on these patients because the cardiologists ry to 
do a balloon dilation whenever they can. 
Dr. Miguel Sousa Uva (Paris, France). I agree with Dr. 
Ilbawi's comments. We too prefer to do an open valvot- 
omy rather than a transventricular pproach. We have 
used a transventricular dilation in the past but without 
cardiopulmonary b pass. 
How many of these patients had left ventricular fibro- 
elastosis and what was the mean aortic anulus diameter? 
Dr. Mosca. As Dr. Robert Freedom pointed out in the 
October 1989 edition of Circulation, neonates with aortic 
stenosis have a complex substrate producing the restric- 
tive aortic orifice. In addition to dysplastic aortic valve 
leaflets, there is marked annular hypoplasia nd at times 
unrecognizable aortic valve commissures. Overall, the 
current literature shows a higher incidence of aortic 
regurgitation and restenosis with open valvotomy. 
We believe that TVD is as safe as BAV and causes 
rupture of the stenotic valves along the fused commissures. 
The mean aortic anulus diameter in the TVD group was 
6.9 mm and in the BAV group, 7.5 ram. Also, the majority 
of our patients had changes of endocardial fibroelastosis. 
The retrograde approach through the right carotid 
artery as reported by the group in Pittsburgh is also a 
viable option. As a retrograde approach it suffers from the 
occasional difficulties of catheterizing the eccentric and 
abnormal aortic orifice. The real danger of a retrograde 
approach is inadvertent cusp perforation leading to mas- 
sive aortic insufficiency. 
In conclusion, we believe TVD with cardiopulmonary 
bypass is the safest, most accurate, and most reproducible 
method available. 
